RxDoctor Payments DataLook up a doctor →

Patricia Gerber, MD

Allergy & Immunology · North Charleston, SCNPI 1023097532

Payments from drug & device makers

$969,951in general payments, 2019–2025

Across 691 payments — averaging $1403.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$310K
  • AstraZeneca$283K
  • LEO Pharma AS$93K
  • Teva Pharmaceuticals USA, Inc.$87K
  • Hikma Pharmaceuticals USA$60K
  • GSK$50K
  • plus $87K from 33 others
$591in research payments, 2019–2025

Across 6 payments — averaging $98.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GSK$591

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$969,951 in reported general payments places this provider in the 90th percentile of 46 allergy & immunology providers in South Carolina.

See all allergy & immunology providers in South Carolina

Medicare billing

Part B allowed, 2024
$167,690
Medicare patients
215
Services billed
6,717

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other allergy & immunology in North Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →